# $dcth Delcath Systems sees a surge in mentions and engagements, driven by discussions around its FDA-approved HEPZATO KIT and potential expansion into new indications. Investors are noting its undervalued status and long-term potential amidst some MedTech sector risks. ### About $dcth Delcath Systems is a medical technology company specializing in cancer treatments, particularly for liver cancers. ### Insights - $dcth mentions hit [---] which is 106% higher than it's daily average. ### Engagements: [-----] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$dcth/time-series/interactions.tsv) Current Value: [-----] Daily Average: [------] [--] Month: [------] -70% [--] Months: [---------] -33% [--] Year: [---------] +62% 1-Year High: [-------] on 2025-03-05 1-Year Low: [---] on 2025-04-22 Engagements by network (24h): Reddit: [--] YouTube: [--] X: [-----] ### Mentions: [---] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$dcth/time-series/posts_active.tsv) Current Value: [---] Daily Average: [--] 1-Year High: [---] on 2025-11-22 1-Year Low: [--] on 2025-09-14 Mentions by network (24h): Reddit: [--] YouTube: [--] X: [---] ### Creators: [--] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$dcth/time-series/contributors_active.tsv) [--] unique social accounts have posts mentioning $dcth in the last [--] hours which is up 124% from [--] in the previous [--] hours Daily Average: [--] 1-Year High: [---] on 2025-06-29 1-Year Low: [--] on 2025-04-12 The most influential creators that mention $dcth in the last [--] hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | [--] | [-----] | [--] | [---] | | [@jud_guy](/creator/twitter/jud_guy) | [--] | [---] | [--] | [---] | | [@em013L](/creator/twitter/em013L) | [--] | [------] | [--] | [---] | | [@Yam_Trades](/creator/twitter/Yam_Trades) | [--] | [-----] | [--] | [---] | | [@Signal_Trader08](/creator/twitter/Signal_Trader08) | [--] | [--] | [--] | [---] | | [@Signal_Trader02](/creator/twitter/Signal_Trader02) | [--] | [--] | [--] | [--] | | [@uboat159](/creator/twitter/uboat159) | [--] | [-----] | [--] | [--] | | [@ryshab](/creator/twitter/ryshab) | [--] | [-----] | [--] | [--] | | [@DarcyHople82406](/creator/twitter/DarcyHople82406) | [--] | [--] | [--] | [--] | | [@Kleem48044](/creator/twitter/Kleem48044) | [--] | [--] | [--] | [--] | [View More](/list/creators/$dcth/100) ### Sentiment: 68%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$dcth/time-series/sentiment.tsv) Current Value: 68% Daily Average: 84% [--] Month: 52% +4% [--] Months: 52% -48% [--] Year: 52% -48% 1-Year High: 100% on 2025-02-14 1-Year Low: 9% on 2025-12-18 Most Supportive Themes: - FDA-Approved Product and Revenue Story: (25%) Delcath has an FDA-approved product, HEPZATO KIT, for liver-dominant uveal melanoma, positioning it as a revenue-generating company rather than a preclinical one. - Expansion into New Indications: (20%) Management is targeting additional indications for their platform, such as colorectal liver metastases, which could lead to a high-margin franchise. - Undervalued with Upcoming Catalysts: (20%) The company is considered undervalued with anticipated catalysts, attracting investors looking for potential growth opportunities. - Long-term Hold Potential: (15%) The stock is viewed as a long-term hold due to its unique position in the MedTech space, offering a contrast to the higher risks associated with biotech. - Informative Podcast Discussion: (10%) A podcast discussed the Chopin trial, providing informative insights into the company's developments. Most Critical Themes: - MedTech Risks: (50%) While distinct from biotech risks, the company operates within the MedTech sector, which inherently carries its own set of risks. - Management Blackout Period: (50%) Potential weakness in the stock may be linked to management entering a blackout period, which could pause buyback activities. ### Top $dcth Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "@Investinc_Intel Current No Brainers in this Stock Market: [--] / $DCTH Oncology Medical Device Worry: Complexity of the Sector [--] / $PLTR AI Software Worry: Still Expensive Valuation [--] / $PGY AI ABS Fintech Worry: State of Consumer Credit [--] / $HOOD Broker Worry: Crypto Markets" [X Link](https://x.com/thephiloinvest/status/2021364702345851164) [@thephiloinvest](/creator/x/thephiloinvest) 2026-02-10T23:24Z [---] followers, [---] engagements "Delcaths largest institutional Investor bought more shares in the end of December The Canadian Biotech fund Rosalind Advisors Inc. increased its $DCTH to 19.76% (previously 11.28%) of the portfolio 13D Filing Increasing its ownership to 19.03% https://investors.delcath.com/node/18876/html https://investors.delcath.com/node/18876/html" [X Link](https://x.com/thephiloinvest/status/2021320361858502720) [@thephiloinvest](/creator/x/thephiloinvest) 2026-02-10T20:28Z [---] followers, [---] engagements "@growthrapidly $AMZN and $GMGI by far - down the line $ABBV $IRMD $IREN $DLO $CIFR $SOFI $DCTH $ONDS $ZETA $GRAB $NU like to get some $MELI & $META again. Should not have sold" [X Link](https://x.com/uboat159/status/2021282270817157561) [@uboat159](/creator/x/uboat159) 2026-02-10T17:57Z [----] followers, [---] engagements "$DAG $DCTH β π Guys Don't miss the next move in a few hours. πΈβ‘ http://discord.com/invite/GZ3Xc87eub http://discord.com/invite/GZ3Xc87eub" [X Link](https://x.com/Signal_Trader08/status/2021207615414681869) [@Signal_Trader08](/creator/x/Signal_Trader08) 2026-02-10T13:00Z [--] followers, [---] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
Delcath Systems sees a surge in mentions and engagements, driven by discussions around its FDA-approved HEPZATO KIT and potential expansion into new indications. Investors are noting its undervalued status and long-term potential amidst some MedTech sector risks.
Delcath Systems is a medical technology company specializing in cancer treatments, particularly for liver cancers.
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Month: [------] -70%
[--] Months: [---------] -33%
[--] Year: [---------] +62%
1-Year High: [-------] on 2025-03-05
1-Year Low: [---] on 2025-04-22
Engagements by network (24h): Reddit: [--] YouTube: [--] X: [-----]
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [--]
1-Year High: [---] on 2025-11-22
1-Year Low: [--] on 2025-09-14
Mentions by network (24h): Reddit: [--] YouTube: [--] X: [---]
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $dcth in the last [--] hours which is up 124% from [--] in the previous [--] hours
Daily Average: [--]
1-Year High: [---] on 2025-06-29
1-Year Low: [--] on 2025-04-12
The most influential creators that mention $dcth in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @NightOwlBiotech | [--] | [-----] | [--] | [---] |
| @jud_guy | [--] | [---] | [--] | [---] |
| @em013L | [--] | [------] | [--] | [---] |
| @Yam_Trades | [--] | [-----] | [--] | [---] |
| @Signal_Trader08 | [--] | [--] | [--] | [---] |
| @Signal_Trader02 | [--] | [--] | [--] | [--] |
| @uboat159 | [--] | [-----] | [--] | [--] |
| @ryshab | [--] | [-----] | [--] | [--] |
| @DarcyHople82406 | [--] | [--] | [--] | [--] |
| @Kleem48044 | [--] | [--] | [--] | [--] |
Sentiment 24-Hour Time-Series Raw Data
Current Value: 68%
Daily Average: 84%
[--] Month: 52% +4%
[--] Months: 52% -48%
[--] Year: 52% -48%
1-Year High: 100% on 2025-02-14
1-Year Low: 9% on 2025-12-18
Most Supportive Themes:
Most Critical Themes:
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"@Investinc_Intel Current No Brainers in this Stock Market: [--] / $DCTH Oncology Medical Device Worry: Complexity of the Sector [--] / $PLTR AI Software Worry: Still Expensive Valuation [--] / $PGY AI ABS Fintech Worry: State of Consumer Credit [--] / $HOOD Broker Worry: Crypto Markets"
X Link @thephiloinvest 2026-02-10T23:24Z [---] followers, [---] engagements
"Delcaths largest institutional Investor bought more shares in the end of December The Canadian Biotech fund Rosalind Advisors Inc. increased its $DCTH to 19.76% (previously 11.28%) of the portfolio 13D Filing Increasing its ownership to 19.03% https://investors.delcath.com/node/18876/html https://investors.delcath.com/node/18876/html"
X Link @thephiloinvest 2026-02-10T20:28Z [---] followers, [---] engagements
"@growthrapidly $AMZN and $GMGI by far - down the line $ABBV $IRMD $IREN $DLO $CIFR $SOFI $DCTH $ONDS $ZETA $GRAB $NU like to get some $MELI & $META again. Should not have sold"
X Link @uboat159 2026-02-10T17:57Z [----] followers, [---] engagements
"$DAG $DCTH β π Guys Don't miss the next move in a few hours. πΈβ‘ http://discord.com/invite/GZ3Xc87eub http://discord.com/invite/GZ3Xc87eub"
X Link @Signal_Trader08 2026-02-10T13:00Z [--] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$dcth